AI & LLM in Medabolic disorders #diabetic #ai #llm #metabolicdisorders

Is Your AI Chatbot Developing a "Fatty Liver"? The Hidden Danger in Medical AI
Think your favorite AI is a medical genius? New research suggests that talking to robots about your health might be "clogging" their digital brains with a condition called AI-MASLD. Just as a human liver suffers from fat accumulation under metabolic stress, Large Language Models like GPT-4o and Gemini 2.5 can experience "Information Steatosis"—a functional decline that occurs when they are overwhelmed by the "metabolic load" of messy, rambling patient stories filled with irrelevant details and emotions. Scientists found that when models face this high-noise data, their ability to filter core medical facts collapses; for example, Gemini 2.5 showed severe impairment, while GPT-4o made a catastrophic misjudgment by missing a fatal pulmonary embolism risk because it was distracted by less urgent symptoms. While some models like Qwen3-Max showed better "metabolic resilience," most still struggle with "algorithmic fibrosis," where they rigidly follow rules and fail to detect logical contradictions or correctly sort chaotic timelines. Because these models still lack the contextual judgment and empathy of a trained clinician, this research serves as a critical safety warning that AI must remain an auxiliary tool under the supervision of human "information gatekeepers".

This video explore the transformative integration of Artificial Intelligence (AI) and multimodal data in managing metabolic disorders like diabetes and steatotic liver disease. These technologies analyze diverse inputs, including wearable device metrics, electronic health records, and advanced imaging, to enable earlier diagnosis and personalized treatment strategies. Large Language Models (LLMs) and generative AI are specifically highlighted for their ability to synthesize unstructured patient data and provide tailored lifestyle recommendations. Despite this potential, the texts emphasize critical challenges regarding data privacy, model transparency, and the necessity for clinical validation in real-world settings. Ultimately, the research aims to shift healthcare from a reactive model to a preventative, precision-driven approach that improves long-term patient outcomes.

#MedicalAI #AIMASLD #HealthTech #AIResearch #FutureOfMedicine #digitalhealth

Видео AI & LLM in Medabolic disorders #diabetic #ai #llm #metabolicdisorders канала Computational GenomeBiology